Analysis-Alzheimer’s drug hunt learns from cancer fight’s multi-target playbook
By Deena Beasley Dec 12 (Reuters) – Alzheimer’s trials testing Novo Nordisk’s blockbuster GLP-1 drug semaglutide, despite their…
Lilly’s GLP-1 Surge Dwarfs Abbott’s Steady Device Growth With 54% Revenue Jump
24/7 Wall St. Abbott Laboratories (ABT) grew revenue 6.9% with medical devices up 14.8% to $5.45B. Abbott reaffirmed…
1 Major Factor Behind the Healthcare Sector’s Recent Surge
Eli Lilly’s GLP-1 drug became the world’s best-selling drug in Q3. Merck, Johnson & Johnson, AbbVie, and other…
Ireland dodged a bullet this year. But there’s a caveat – The Irish Times
The Irish economy dodged a bullet this year. Several of them, in fact. Back in April, we were…
Ireland has two economies, one bourgeois, one proletarian. Both have problems – The Irish Times
How do you know our rulers are spoofing? A cynic might say the tell is that they have…
Eli Lilly Trims Price of Popular Weight-Loss Drug on Its Site a Month After Trump Deal
Shelby Knowles / Bloomberg / Getty Images Eli Lilly shares have added over a third of their value…
Lilly cuts price for obesity drug Zepbound
Trump announces lower prices coming for GLP-1 drugs Zepbound, Wegovy President Donald Trump announces discounted pricing for Zepbound…
Seasoned Healthcare Executive Raises $52 Million For An AI Health Startup
Michelle Carnahan has spent the better part of the last three decades working in healthcare at companies like…
This Healthcare Company Just Touched $1 Trillion in Market Cap. Should You Invest $1,000?
Eli Lilly has a dominant share of the huge and expanding GLP-1 drug market. Its GLP-1 drugs will…
Why big pharma is teaming up with AI giants to speed up drug discovery and make work easier for health care workers
AI chip maker Nvidia’s fresh partnerships with Eli Lilly and Johnson & Johnson point to a broader trend…
Why big pharma is teaming up with AI giants to speed up drug discovery and make work easier for health care workers
AI chip maker Nvidia’s fresh partnerships with Eli Lilly and Johnson & Johnson point to a broader trend…
Deal With Eli Lilly Propels Founder Of Korean Biotech Firm Into Billionaire Ranks
A $2.6 billion licensing and joint research deal with Eli Lilly boosted shares of South Korean biotech company…